Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease

NCT01280123 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.

NCT NCT01280123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01280123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Lead sponsor
University of Rochester
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2011
Completion date
May 31, 2014
Enrollment
210 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease